pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.

Marketing 100

Marketing Doctor Doctors Pharma Companies 100

World of DTC Marketing

DECEMBER 14, 2021

Third, the arguments that high costs are needed for continued innovation and that attempts to lower or regulate the prices will hamper innovation are not valid excuses. There is limited innovation when it comes to insulin; the more pressing need is affordability. The list price of insulin has increased between 300% to 500%.

Insulin 184

Insulin Branding Drugs Production 184

pharmaphorum

OCTOBER 15, 2020

The boom in digital tech over COVID means that pharma can move faster than ever – but the industry’s traditional processes for asset approval are still holding timelines back. David Reily examines how pharma companies are responding to the increased burden of asset approval with new ways of working. Bhupinder McJennett, AbbVie.

Compliance 131

Compliance Pharma Companies Marketing Regulation 131

Pharma Marketing Network

SEPTEMBER 14, 2020

The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. The video creation ideas below can be immediately executed and could potentially make a huge difference for your sales team and between your reps and HCPs. HCP Patient Education.

Sales 105

Sales Pharma Companies Nurses Compliance 105

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. For example, price regulations are becoming more common in Latin America, often being based on models such as NICE’s.

Marketing 109

Marketing Regulation Production Medicine 109

pharmaphorum

JULY 15, 2021

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS. The regulator says that the in addition to the fines, the NHS may choose to pursue the companies for damages in the courts.

Marketing 119

Marketing Sales Pharma Companies Medicine 119

pharmaphorum

APRIL 30, 2021

Savana’s Dr Ignacio Medrano explains how natural language processing technology is opening up huge amounts of previously-inaccessible real-world evidence for pharma and regulators. Research predicts the post-COVID landscape for HCP engagement. A year on: pandemic driven trends in HCP Engagement. Subscribe to future issues of Deep Dive.

Marketing 98

Marketing Sales Regulation Drugs 98

pharmaphorum

FEBRUARY 14, 2022

The easy answer as to why this has happened can be quickly linked to the COVID-19 pandemic, where sales of vaccines and treatments led to a large increase in return on investment and sales projections. As a result, the estimated peak sales of assets increased from $360 million to $521 million in 2019 and 2021, respectively.

Production 98

Production Clinical Trials Clinical Trials Sales 98

pharmaphorum

AUGUST 4, 2020

Redx is also eligible for tiered royalties of mid-single digit percentages, based on any future net sales. The deal consisted of a $29m loan and a $1m investment and gave the company enough funding to carry on its R&D work into next year. The post Redx shares soar after IPF drug licence deal with AstraZeneca appeared first on.

Drugs 109

Drugs Clinical Trials Clinical Trials Trials 109

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Dermatology 118

Dermatology Production Pharma Companies Marketing 118

pharmaphorum

SEPTEMBER 15, 2020

This gives them huge amounts of customer data that allows them to shape and personalise the way they engage with their customers, not least thanks to the direct-to-consumer sales model they often offer. As part of this, a number of big pharma companies are also racing to develop a safe and effective vaccine for the coronavirus.

Branding 130

Branding Marketing Pharma Companies Life Science 130

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?

Compliance 119

Compliance Regulation Manufacturing Licensing 119

World of DTC Marketing

JUNE 16, 2021

About eight in ten across partisans say profits made by pharmaceutical companies are a “major factor” in the price of prescription drugs. The May 2021 KFF Health Tracking Poll finds about two-thirds of adults say there is “not as much regulation as there should be” when it comes to limiting the price of prescription drugs.

Drugs 180

Drugs Branding Medicine Insulin 180

pharmaphorum

DECEMBER 22, 2021

Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. CFI regulates the activity of the complement immune system which is over-activated in GA. It has been fast-tracked by the FDA.

Gene Therapy 105

Gene Therapy Gene Licensing Licensing 105

Pharma Marketing Network

DECEMBER 31, 2024

Pharma marketing executives face unique challenges like regulatory restrictions, stiff competition, and shifting consumer expectations. So, how can you build trust, boost brand awareness, and still drive sales? Ensure Regulatory Compliance Navigating regulations can feel daunting, but its crucial.

Marketing 52

Marketing Branding Compliance Drugs 52

pharmaphorum

NOVEMBER 30, 2022

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

JANUARY 10, 2023

The company has had huge success in delivering success for clients across consumer sectors and it has now established a track record in health by deploying sophisticated software, machine learning, and AI to empower all aspects of pharma company performance. Better customer experience. To learn more, visit www.treasuredata.com.

Marketing 98

Marketing Life Science Sales Branding 98

pharmaphorum

MAY 25, 2022

The move to online international meetings has left pharma companies with uncertainty around contact compliance. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity.

Regulation 105

Regulation Compliance Manufacturing Medicine 105

Pharma Marketing Network

SEPTEMBER 14, 2020

The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. The video creation ideas below can be immediately executed and could potentially make a huge difference for your sales team and between your reps and HCPs. HCP Patient Education.

Sales 69

Sales Pharma Companies Nurses Compliance 69

pharmaphorum

JANUARY 26, 2023

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time. It has drawn up the guidance with the help of the companies, the ABPI, and UK regulator the MHRA.

Medicine 105

Medicine Pharma Companies Clinical Trials Clinical Trials 105

Pharma Marketing Network

OCTOBER 1, 2024

Introduction to Pharma Marketing Strategies Pharma marketing strategies encompass a range of activities aimed at promoting pharmaceutical products to healthcare professionals and consumers. These strategies are designed to increase brand awareness, educate the target audience, and ultimately drive sales.

Marketing 52

Marketing Pharma Companies Regulation Production 52

pharmaphorum

JANUARY 26, 2021

Life sciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. Pharma companies will need to continually rethink what works and not be afraid to experiment with solutions they’ve never tried before. As such, reps will need to be reskilled.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. global growth for the year ahead.

Manufacturing 162

Manufacturing Marketing Production Drugs 162

Pharma Marketing Network

MARCH 17, 2025

With increasing competition and stricter compliance regulations, pharma marketing teams must adopt data-driven and personalized marketing strategies to capture the attention of HCPs. But how can pharma brands stand out in a crowded market?

Branding 52

Branding Marketing Compliance Pharma Companies 52

Pharma Marketing Network

OCTOBER 28, 2023

In this article, we will explore the concept of patient-centricity, its impact on digital communication in pharma, the benefits it brings, and the challenges it presents for pharma companies. Benefits of Patient-Centricity The shift to patient-centricity has many benefits for both patients and pharma companies.

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

pharmaphorum

NOVEMBER 16, 2022

The North Ireland Protocol has been a source of tension between the UK and EU since it came into force at the start of 2021 – and according to one pharma company the end of the so-called ‘grace period’ could result in major issues with medicines supply.

Medicine 105

Medicine Production Pharma Companies Regulation 105

pharmaphorum

APRIL 27, 2022

Using a syndicated and impartial benchmarking service, such as CSL’s Omni Benchmarking service for pharma, allows companies to evaluate their performance against an agreed set of omnichannel metrics. This includes Machine learning, Data warehousing, Sales performance management & Patient outcome analysis.

Marketing 116

Marketing Sales Production Development 116

Pharma Marketing Network

OCTOBER 14, 2024

Among these, influencer marketing has emerged as a powerful tool for pharma companies seeking to build trust and foster engagement with their target audiences. Unlike mainstream social media influencers, those in the pharma sector often have smaller but highly engaged audiences that value their professional opinions and insights.

Marketing 52

Marketing Branding Pharma Companies Production 52

Pharma Marketing Network

JANUARY 29, 2025

With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. AI-powered chatbots, predictive modeling, and automated sales reps are reshaping HCP engagement and patient support. Why is personalized medicine important for pharma marketing?

Marketing 52

Marketing Compliance Big Data Branding 52

pharmaphorum

JANUARY 6, 2021

The regulator said it wanted more long-term safety and efficacy data from the REGENERATE study before making a final decision on the drug, which had been expected to be the first entrant into a likely multi-billion dollar market niche. billion annually if approved.

Gene Silencing 52

Gene Silencing Regulation Pharma Companies Trials 52

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. global growth for the year ahead.

Manufacturing 130

Manufacturing Production Marketing Drugs 130

Pharma Marketing Network

MARCH 3, 2025

Data-Driven Personalization : Using real-time insights, pharma companies can deliver tailored content to physicians and patients. However, pharma marketers must navigate strict compliance regulations to avoid misleading advertising or privacy violations. How do pharma brands ensure compliance in digital advertising?

Compliance 52

Compliance Branding Doctors Doctor 52

Pharma Marketing Network

MARCH 3, 2025

Data-Driven Personalization : Using real-time insights, pharma companies can deliver tailored content to physicians and patients. However, pharma marketers must navigate strict compliance regulations to avoid misleading advertising or privacy violations. How do pharma brands ensure compliance in digital advertising?

Compliance 52

Compliance Branding Doctors Doctor 52

XTalks

MARCH 28, 2024

Bettica said the company’s focus is to now “make Duvyzat available as a treatment for DMD management in the US as quickly as possible.” In November, the FDA extended its decision deadline by three months to allow extra time for regulators to review additional information submitted by Italfarmaco as part of a new drug application.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

OCTOBER 7, 2021

Rewind to March of 2020, and pharma companies were facing a communication crisis. Thankfully, many pharma companies had already started on a journey towards digital engagement, and healthcare professionals (HCPs) are embracing the medium more than ever before, thanks in part to newer generations who are increasingly digitally-savvy.

Pharma Companies 75

Pharma Companies Production Clinical Trials Clinical Trials 75

pharmaphorum

FEBRUARY 25, 2022

Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. Therefore, harnessing this new collaborative approach could be the best way to strengthen trust in pharma. The past two years have shone a spotlight on the UK life sciences industry.

Life Science 98

Life Science Vaccination Vaccine Pharmacy 98

XTalks

MARCH 22, 2023

While not a record-breaking deal at $17 billion, the buyout strengthened Pfizer’s injectables business unit with the company reporting an 11 percent increase in revenue the following year. More potential patients equal more prescriptions which equals higher sales and bigger profits.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97